Cancer Treatment Options and Management

Cancer Treatment Options and Management, commonly branded as CTOAM, is a Canada-based precision oncology and cancer care services company focused on helping patients access advanced diagnostics, second-opinion support, and personalized treatment planning. Rather than developing proprietary therapeutic drugs, the company appears to operate as a patient-facing oncology navigation and research-driven advisory organization that works with patients and their treating oncologists. CTOAM emphasizes molecular profiling, including tumor DNA and RNA sequencing, liquid biopsy, advanced imaging, and treatment-access support for targeted therapies and other personalized cancer interventions. The company markets its services globally from Canada and positions itself as an independent precision cancer medicine specialist and care concierge. Its business is best characterized as commercial healthcare services in precision oncology rather than a traditional biotech or pharma drug developer.